Zorbtive and blood thyroid stimulating hormone decreased Patient Reports February 11, 2012

Zorbtive Side Effects Report #5481123-5
Zorbtive side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Male patient, 41 years of age, weighting 157.0 lb, was diagnosed with short-bowel syndrome and was treated with Zorbtive. After drug was administered, patient experienced the following side effects: arthralgia, blood testosterone decreased, blood testosterone free decreased, blood thyroid stimulating hormone decreased, breast engorgement, breast tenderness, chest pain , clostridial infection, diarrhoea. Zorbtive dosage: 8.4 MG, 1 IN 1 DAYS, SUBCUTANEOUS; 6.5 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with REMICADE, HUMIRA. Patient was hospitalized. Patient recovered.